Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 171.10% vs -14.06% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -196.72% vs 551.85% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -150.00% vs 194.00% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 91.67% vs 9.09% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Genpharmasec With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 171.10% vs -14.06% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 441.29% vs -23.28% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -196.72% vs 551.85% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -268.57% vs 6,900.00% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -150.00% vs 194.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -491.67% vs 400.00% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 91.67% vs 9.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 228.57% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






